NCT00491725View on ClinicalTrials.gov

Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs

PHASE4CompletedINTERVENTIONAL

Enrollment

187

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

repaglinide

DRUG

metformin

Trial Locations (1)

100034

Beijing

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY